Omnia SanaPlant Comparison
Bistort vs Bay-leaf willowherb
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Bistort and Bay-leaf willowherb: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Bistort | Bay-leaf willowherb | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Very high tannin content is the basis of the strong astringency.
Contribute to antioxidant and antibacterial activity.
Characteristic Epilobium polyphenols underlying the anti-inflammatory and prostate activity; a genus review identifies oenothein B as the dominant constituent and likely driver of the antimicrobial, anti-inflammatory, anti-proliferative and antioxidant effects.
Antioxidant constituents.
Sterols associated with benign prostatic hyperplasia support.
Pharmacological Actions
Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)
Bistorta officinalis (Polygonum bistorta) rhizome extract, rich in gallotannins and phenolic acids, shows cytotoxic and pro-apoptotic activity against hepatocellular and other cancer cells (preclinical).
Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)
Antibacterial (topical) - GC-MS-characterised extracts showed antibacterial activity
Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Polygonum bistorta (Bistorta officinalis) methanol-water and aqueous extracts inhibit hepatocellular carcinoma cells via ROS-induced ER stress and apoptosis (delaying xenograft tumour growth), with phenolic constituents driving the cytotoxicity (preclinical).
Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)
inferred from styptic action
inferred from antimicrobial action
Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)
inferred from astringent action
Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)
inferred from anti-inflammatory action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
inferred from anti-inflammatory action
Antibacterial, including against Escherichia coli (urinary support); Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive
Safety, Cautions & Contraindications
Very tannin-rich: high or prolonged intake may cause stomach upset or constipation and can reduce the absorption of iron and some medicines taken at the same time.
Traditional use only; diarrhoea persisting beyond a few days, or mouth/throat inflammation that does not settle, needs medical assessment.
Safety in pregnancy and breastfeeding is not established; avoid medicinal doses.
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer; willowherb is a supportive measure, not a substitute for diagnosis and treatment.
Well tolerated over three months in clinical use; longer-term safety data are limited.
External Ids
Botanical Description
Perennial herb rising from a thick, twisted, S- or snake-shaped rhizome (giving the names 'bistort' and 'snakeroot'), blackish outside and pink inside. The basal leaves are broadly oval to lance-shaped on long stalks; stem leaves are smaller and stalkless. A single dense, cylindrical spike of small, pale pink flowers is borne atop each unbranched flowering stem.[14]
Slender, softly hairy perennial herb with narrow, lance-shaped leaves and small, four-petalled, pale pink to lilac flowers with a notched tip, borne singly in the upper leaf axils. After flowering, long, narrow seed pods split to release cottony-tufted seeds, typical of the willowherb genus.[13]
Habitat
Harvesting
The rhizome is dug in autumn or early spring, when tannin content is highest, cleaned and dried; aerial parts are gathered in summer while flowering.[14]
The flowering aerial parts are cut in summer while in flower, and dried in a warm, shaded, airy place.[13]
Traditional Uses
Bistort rhizome, one of the most tannin-rich temperate herbs, has a long European folk history as a powerful astringent for mild diarrhoea, as a gargle for sore throat and mouth inflammation, and topically as a vulnerary and styptic for minor wounds and bleeding; young leaves have also traditionally been eaten as a spring pot-herb ('Easter-ledge pudding').[13, 14]
Small-flowered willowherb, along with related Epilobium species, has a Central European folk tradition as a supportive remedy for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) and prostatitis, and as an antimicrobial and anti-inflammatory herb for minor infections; the traditional prostate-support use is attributed mainly to its oenothein B content, though robust clinical evidence remains limited.[13]
Preparations
Dried flowering herb infused in hot water as a traditional urinary and prostate-support tea.
References
Lookalikes Review
Dosage
Not documented
The EU herbal monograph gives 1.5-2.0 g of the comminuted herb in 250 mL of boiling water as an infusion, twice daily, in adults and elderly; long-term use is possible. Lower urinary tract or prostate symptoms should always be medically assessed first, and the monograph directs that a doctor be consulted if fever, spasms, blood in the urine, painful urination or urinary retention occur. Educational reference only, not a prescription.
References & Sources
- Pawłowska, K.A., Hałasa, R., Dudek, M.K., Majdan, M. et al (2020) 'Antibacterial and anti-inflammatory activity of bistort (Bistorta officinalis) aqueous extract and its major components: justification of the usage of the medicinal plant material as a traditional topical agent', Journal of Ethnopharmacology, 260, pp. 113077. doi:10.1016/j.jep.2020.113077 Preclinical
https://doi.org/10.1016/j.jep.2020.113077 - Jovanović, M., Morić, I., Nikolić, B., Pavić, A. et al (2020) 'Anti-Virulence Potential and In Vivo Toxicity of Persicaria maculosa and Bistorta officinalis Extracts', Molecules, 25(8), pp. 1811. doi:10.3390/molecules25081811 Preclinical
https://doi.org/10.3390/molecules25081811 - Duwiejua, M., Zeitlin, I.J., Waterman, P.G. and Gray, A.I (1994) 'Anti-inflammatory activity of Polygonum bistorta, Guaiacum officinale and Hamamelis virginiana in rats', Journal of Pharmacy and Pharmacology, 46(4), pp. 286-290. doi:10.1111/j.2042-7158.1994.tb03795.x Preclinical
https://doi.org/10.1111/j.2042-7158.1994.tb03795.x - Esmaealzadeh, N., Abdolghaffari, A., Baeeri, M., Hasanpour, M., Iranshahi, M., Santarcangelo, C., Gholami, M. and Bahramsoltani, R (2024) 'Protective effect of freeze-dried extract of Persicaria bistorta Samp. on acetic acid-induced colitis model in rats: involvement of nitric oxide and opioid system', Inflammopharmacology, 32(6), pp. 3845-3861. doi:10.1007/s10787-024-01518-8 Preclinical
https://doi.org/10.1007/s10787-024-01518-8 - Klimczak, U., Wozniak, M., Tomczyk, M. and Granica, S (2017) 'Chemical composition of edible aerial parts of meadow bistort (Persicaria bistorta (L.) Samp.)', Food Chemistry, 230, pp. 281-290. doi:10.1016/j.foodchem.2017.02.128 Preclinical
https://doi.org/10.1016/j.foodchem.2017.02.128 - Manoharan, K.P., Benny, T.K.H. and Yang, D (2005) 'Cycloartane type triterpenoids from the rhizomes of Polygonum bistorta', Phytochemistry, 66(19), pp. 2304-2308. doi:10.1016/j.phytochem.2005.07.008 Preclinical
https://doi.org/10.1016/j.phytochem.2005.07.008 - Liu, X., Hua, H., Liu, J., Chen, F. and Wu, L (2006) 'A new tannin-related compound from the rhizome of Polygonum bistorta L', Journal of Asian Natural Products Research, 8(4), pp. 299-302. doi:10.1080/10286020500034956 Preclinical
https://doi.org/10.1080/10286020500034956 - Yang, W., Qian, Z., Wu, M., Gao, J., Huang, Q., Zou, Y. and Tang, D (2023) 'Online microextraction coupled with HPLC-ABTS for rapid analysis of antioxidants from the root of Polygonum bistorta', Evidence-Based Complementary and Alternative Medicine, 2023, pp. 7496848. doi:10.1155/2023/7496848 Preclinical
https://doi.org/10.1155/2023/7496848 - Bauer, I., Rimbach, G., Nevermann, S., Neuhauser, C., Schwarzinger, B., Schwarzinger, C., Weghuber, J. and Luersen, K (2023) 'In-vitro antidiabetic activity of a Bistorta officinalis Delarbre root extract can not be confirmed in the in-vivo models hen's egg test and Drosophila melanogaster', Journal of Physiology and Pharmacology, 74(1). doi:10.26402/jpp.2023.1.04 Preclinical
https://doi.org/10.26402/jpp.2023.1.04 - Intisar, A., Zhang, L., Luo, H., Kiazolu, J.B., Zhang, R. and Zhang, W (2012) 'Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L', African Journal of Traditional, Complementary and Alternative Medicines, 10(1), pp. 53-59. doi:10.4314/ajtcam.v10i1.9 Preclinical
https://doi.org/10.4314/ajtcam.v10i1.9 - Liu, Y., Weng, Y., Lin, H., Tang, S., Chen, C., Liang, C., Ku, C. and Lin, J (2017) 'Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells', Scientific Reports, 7, pp. 41437. doi:10.1038/srep41437 Preclinical
https://doi.org/10.1038/srep41437 - Khan, S., Arshad, S., Masood, I., Arif, A., Abbas, S., Qureshi, A.W., Parveen, A. and Seemab Ameen, Z (2023) 'GC-MS Analysis of Persicaria bistorta: Uncovering the Molecular Basis of Its Traditional Medicinal Use', Applied Biochemistry and Biotechnology, 196(4), pp. 2270--2288. doi:10.1007/s12010-023-04580-0 Traditional / reference
https://doi.org/10.1007/s12010-023-04580-0 - WebMD (n.d.) 'Bistort: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-75/bistort Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-75/bistort - (2020) 'Antibacterial and anti-inflammatory activity of bistort (Bistorta officinalis) aqueous extract and its major components - justification of the usage of the medicinal plant material as a traditional topical agent', Journal of Ethnopharmacology. doi:10.1016/j.jep.2020.113077 Traditional / reference
https://doi.org/10.1016/j.jep.2020.113077
- Vitalone, A. and Allkanjari, O (2018) 'Epilobium spp: Pharmacology and Phytochemistry', Phytotherapy Research, 32(7), pp. 1229-1240. doi:10.1002/ptr.6072 Traditional / reference
https://doi.org/10.1002/ptr.6072 - Cicero, A.F.G., Allkanjari, O., Busetto, G.M., Cai, T. et al (2019) 'Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer', Archivio Italiano di Urologia e Andrologia, 91(3), pp. 139-152. doi:10.4081/aiua.2019.3.139 Traditional / reference
https://doi.org/10.4081/aiua.2019.3.139 - Vlase, A.M., Toiu, A., Gligor, O., Muntean, D. et al (2024) 'Investigation of Epilobium hirsutum L. Optimized Extract's Anti-Inflammatory and Antitumor Potential', Plants (Basel), 13(2), pp. 198. doi:10.3390/plants13020198 Preclinical
https://doi.org/10.3390/plants13020198 - Granica, S., Piwowarski, J.P., Czerwinska, M.E. and Kiss, A.K (2014) 'Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review', Journal of Ethnopharmacology, pp. 316--346. doi:10.1016/j.jep.2014.08.036 Traditional / reference
https://doi.org/10.1016/j.jep.2014.08.036 - Ramstead, A.G., Schepetkin, I.A., Quinn, M.T. and Jutila, M.A (2012) 'Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFN-gamma production by lymphocytes', PLoS One, 7(11), pp. e50546. doi:10.1371/journal.pone.0050546 Preclinical
https://doi.org/10.1371/journal.pone.0050546 - Kiss, A.K., Bazylko, A., Filipek, A., Granica, S., Jaszewska, E., Kiarszys, U., Kosmider, A. and Piwowarski, J (2011) 'Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp', Phytomedicine, 18(7), pp. 557-560. doi:10.1016/j.phymed.2010.10.016 Preclinical
https://doi.org/10.1016/j.phymed.2010.10.016 - Schepetkin, I.A., Kirpotina, L.N., Jakiw, L., Khlebnikov, A.I., Blaskovich, C.L., Jutila, M.A. and Quinn, M.T (2009) 'Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium', Journal of Immunology, 183(10), pp. 6754-6766. doi:10.4049/jimmunol.0901827 Preclinical
https://doi.org/10.4049/jimmunol.0901827 - Ducrey, B., Marston, A., Gohring, S., Hartmann, R.W. and Hostettmann, K (1997) 'Inhibition of 5-alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species', Planta Medica, 63(2), pp. 111-114. doi:10.1055/s-2006-957624 Preclinical
https://doi.org/10.1055/s-2006-957624 - Schepetkin, I.A., Ramstead, A.G., Kirpotina, L.N., Voyich, J.M., Jutila, M.A. and Quinn, M.T (2016) 'Therapeutic potential of polyphenols from Epilobium angustifolium (fireweed)', Phytotherapy Research, 30(8), pp. 1287-1297. doi:10.1002/ptr.5648 Meta-analysis / review
https://doi.org/10.1002/ptr.5648 - Merighi, S., Travagli, A., Tedeschi, P., Marchetti, N. and Gessi, S (2021) 'Antioxidant and anti-inflammatory effects of Epilobium parviflorum, Melilotus officinalis and Cardiospermum halicacabum plant extracts in macrophage and microglial cells', Cells, 10(10), pp. 2691. doi:10.3390/cells10102691 Preclinical
https://doi.org/10.3390/cells10102691 - Hevesi Toth, B., Blazics, B. and Kery, A (2009) 'Polyphenol composition and antioxidant capacity of Epilobium species', Journal of Pharmaceutical and Biomedical Analysis, 49(1), pp. 26-31. doi:10.1016/j.jpba.2008.09.047 Preclinical
https://doi.org/10.1016/j.jpba.2008.09.047 - Vitalone, A., McColl, J., Thome, D., Costa, L.G. and Tita, B (2003) 'Characterization of the effect of Epilobium extracts on human cell proliferation', Pharmacology, 69(2), pp. 79-87. doi:10.1159/000072360 Preclinical
https://doi.org/10.1159/000072360 - Steenkamp, V., Gouws, M.C., Gulumian, M., Elgorashi, E.E. and van Staden, J (2005) 'Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis', Journal of Ethnopharmacology, pp. 2005. doi:10.1016/j.jep.2005.07.007 Traditional / reference
https://doi.org/10.1016/j.jep.2005.07.007 - European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf - Coulson, S., Rao, A., Beck, S.L., Steels, E., Gramotnev, H. and Vitetta, L (2013) 'A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation (containing Epilobium parviflorum) for the management of symptoms of benign prostatic hypertrophy', Complementary Therapies in Medicine. doi:10.1016/j.ctim.2013.01.007 Randomized trial
https://doi.org/10.1016/j.ctim.2013.01.007
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.